Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis.
<h4>Background and aim</h4>COVID-19 pandemic burdens the healthcare systems, causes healthcare avoidance, and might worsen the outcomes of inflammatory bowel disease (IBD) management. We aimed to estimate the impact of pandemic-related avoidance on outpatient IBD management, and the cost...
Main Authors: | Jiaqi Yao, Ginenus Fekadu, Xinchan Jiang, Joyce H S You |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0266464 |
Similar Items
-
Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.
by: Ginenus Fekadu, et al.
Published: (2022-01-01) -
Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
by: Ginenus Fekadu, et al.
Published: (2022-11-01) -
Comparative Cost-Effectiveness Analysis of Respiratory Syncytial Virus Vaccines for Older Adults in Hong Kong
by: Yingcheng Wang, et al.
Published: (2023-10-01) -
Telemonitoring: ethical lessons from the COVID-19 pandemic
by: Ineke Bolt, et al.
Published: (2023-11-01) -
Cost-Effectiveness Analyses of Digital Health Technology for Improving the Uptake of Vaccination Programs: Systematic Review
by: Yingcheng Wang, et al.
Published: (2023-05-01)